Arrowstreet Capital, Limited Partnership Vanda Pharmaceuticals Inc. Transaction History

Arrowstreet Capital, Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $127,449 - $195,641	29,778 New	29,778 $129,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $947,413 - $1.2 Million	-101,763 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $1.76 Million - $2.69 Million	-162,766 Reduced 61.53%	101,763 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $1.22 Million - $1.64 Million	-77,714 Reduced 22.71%	264,529 $4.15 Million
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $1.22 Million - $1.68 Million	-79,179 Reduced 18.79%	342,243 $5.87 Million
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $6.62 Million - $9.06 Million	421,422 New	421,422 $9.07 Million
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $702,713 - $990,737	-52,559 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $924,512 - $1.63 Million	52,559 New	52,559 $967,000

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.